drugset / Trial / NCT00781521

Safety and Efficacy of Floxin Otic Solution in the Treatment of Acute Otitis Media in Children

NCT00781521

Phase 3 Completed 96 enrolled Daiichi Sankyo
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This was a pilot study to determine the safety and effectiveness of a twice daily, seven-day dosing regimen in acute, pediatric, otitis media in children with tympanostomy tubes. The currently approved regimen is twice daily for 10 days.

Timeline

Start
2002-11
Primary completion
2003-04
Completion
2003-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Ofloxacin Small molecule 0.3 % Other

Indications